HEADER TRANSFERASE 16-MAR-11 2YCR TITLE CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR TITLE 2 PV976 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 210-531; COMPND 5 SYNONYM: CHECKPOINT KINASE 2, CDS1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDZ1927 KEYWDS TRANSFERASE, ANTICANCER DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR G.T.LOUNTOS,A.G.JOBSON,J.E.TROPEA,C.R.SELF,Y.POMMIER,R.H.SHOEMAKER, AUTHOR 2 G.ZHANG,D.S.WAUGH REVDAT 2 20-DEC-23 2YCR 1 REMARK REVDAT 1 16-NOV-11 2YCR 0 JRNL AUTH G.T.LOUNTOS,A.G.JOBSON,J.E.TROPEA,C.R.SELF,G.ZHANG, JRNL AUTH 2 Y.POMMIER,R.H.SHOEMAKER,D.S.WAUGH JRNL TITL STRUCTURAL CHARACTERIZATION OF INHIBITOR COMPLEXES WITH JRNL TITL 2 CHECKPOINT KINASE 2 (CHK2), A DRUG TARGET FOR CANCER JRNL TITL 3 THERAPY. JRNL REF J.STRUCT.BIOL. V. 176 292 2011 JRNL REFN ISSN 1047-8477 JRNL PMID 21963792 JRNL DOI 10.1016/J.JSB.2011.09.008 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0104 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 21747 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1178 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1584 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 80 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 145 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.21000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : -0.32000 REMARK 3 B12 (A**2) : 0.11000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.203 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.115 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.862 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2341 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1612 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3157 ; 1.454 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3962 ; 0.880 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 281 ; 5.166 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;35.942 ;24.896 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 442 ;15.674 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;20.533 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2521 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 447 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1410 ; 0.692 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 567 ; 0.134 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2281 ; 1.298 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 931 ; 1.846 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 875 ; 3.063 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 211 A 300 REMARK 3 ORIGIN FOR THE GROUP (A): -39.3069 42.5290 11.7441 REMARK 3 T TENSOR REMARK 3 T11: 0.2624 T22: 0.1385 REMARK 3 T33: 0.0924 T12: 0.0419 REMARK 3 T13: -0.0119 T23: 0.0209 REMARK 3 L TENSOR REMARK 3 L11: 7.4210 L22: 2.0318 REMARK 3 L33: 0.1410 L12: -3.6831 REMARK 3 L13: 0.1164 L23: -0.0219 REMARK 3 S TENSOR REMARK 3 S11: -0.3687 S12: -0.4419 S13: -0.1330 REMARK 3 S21: 0.2922 S22: 0.3005 S23: 0.0653 REMARK 3 S31: 0.2608 S32: -0.0601 S33: 0.0683 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 301 A 374 REMARK 3 ORIGIN FOR THE GROUP (A): -26.9137 28.3758 6.0007 REMARK 3 T TENSOR REMARK 3 T11: 0.1247 T22: 0.0622 REMARK 3 T33: 0.0531 T12: 0.0311 REMARK 3 T13: -0.0450 T23: -0.0406 REMARK 3 L TENSOR REMARK 3 L11: 3.5985 L22: 3.1000 REMARK 3 L33: 3.6865 L12: -0.7314 REMARK 3 L13: 0.9799 L23: 0.3920 REMARK 3 S TENSOR REMARK 3 S11: -0.0128 S12: 0.1802 S13: -0.2010 REMARK 3 S21: -0.3580 S22: -0.1180 S23: 0.3503 REMARK 3 S31: -0.1007 S32: -0.2777 S33: 0.1309 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 375 A 448 REMARK 3 ORIGIN FOR THE GROUP (A): -16.6667 20.4552 21.8371 REMARK 3 T TENSOR REMARK 3 T11: 0.0544 T22: 0.0449 REMARK 3 T33: 0.1218 T12: 0.0088 REMARK 3 T13: 0.0591 T23: -0.0004 REMARK 3 L TENSOR REMARK 3 L11: 1.6244 L22: 1.1652 REMARK 3 L33: 2.8689 L12: 0.0369 REMARK 3 L13: 1.4889 L23: 0.7384 REMARK 3 S TENSOR REMARK 3 S11: -0.1098 S12: -0.0098 S13: -0.1598 REMARK 3 S21: -0.1115 S22: -0.0071 S23: 0.0763 REMARK 3 S31: -0.0089 S32: 0.0589 S33: 0.1169 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 449 A 510 REMARK 3 ORIGIN FOR THE GROUP (A): -16.0634 25.4188 0.7098 REMARK 3 T TENSOR REMARK 3 T11: 0.2593 T22: 0.2379 REMARK 3 T33: 0.1081 T12: 0.0342 REMARK 3 T13: 0.0514 T23: -0.0104 REMARK 3 L TENSOR REMARK 3 L11: 1.6753 L22: 1.4805 REMARK 3 L33: 0.5095 L12: -0.2005 REMARK 3 L13: -0.4162 L23: -0.3692 REMARK 3 S TENSOR REMARK 3 S11: 0.0438 S12: 0.2725 S13: -0.1126 REMARK 3 S21: -0.3505 S22: -0.2022 S23: -0.2582 REMARK 3 S31: 0.0598 S32: 0.2404 S33: 0.1584 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YCR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1290047728. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22945 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 47.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2CN5 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.8, 0.1M MAGNESIUM REMARK 280 NITRATE, 14% W/V PEG 3350, 16% V/V ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.25467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 31.12733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 31.12733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 62.25467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 62.25467 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 209 REMARK 465 SER A 210 REMARK 465 GLY A 229 REMARK 465 ALA A 230 REMARK 465 CYS A 231 REMARK 465 ARG A 254 REMARK 465 LYS A 255 REMARK 465 PHE A 256 REMARK 465 ALA A 257 REMARK 465 ILE A 258 REMARK 465 GLY A 259 REMARK 465 SER A 260 REMARK 465 ALA A 261 REMARK 465 ARG A 262 REMARK 465 GLU A 263 REMARK 465 ALA A 264 REMARK 465 ASP A 265 REMARK 465 PRO A 266 REMARK 465 ALA A 267 REMARK 465 LEU A 268 REMARK 465 VAL A 511 REMARK 465 LEU A 512 REMARK 465 ALA A 513 REMARK 465 GLN A 514 REMARK 465 PRO A 515 REMARK 465 SER A 516 REMARK 465 THR A 517 REMARK 465 SER A 518 REMARK 465 ARG A 519 REMARK 465 LYS A 520 REMARK 465 ARG A 521 REMARK 465 PRO A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 GLY A 525 REMARK 465 GLU A 526 REMARK 465 ALA A 527 REMARK 465 GLU A 528 REMARK 465 GLY A 529 REMARK 465 ALA A 530 REMARK 465 GLU A 531 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 271 CG CD OE1 OE2 REMARK 470 GLU A 275 CG CD OE1 OE2 REMARK 470 ARG A 431 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2090 O HOH A 2129 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 223 -146.63 -138.19 REMARK 500 GLU A 233 141.70 -170.29 REMARK 500 ALA A 294 -135.05 -116.79 REMARK 500 ARG A 346 -0.95 77.02 REMARK 500 ASP A 368 83.31 64.45 REMARK 500 PRO A 388 32.09 -85.85 REMARK 500 LEU A 467 49.00 -93.23 REMARK 500 SER A 505 -83.25 174.77 REMARK 500 THR A 506 133.45 99.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HCW A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WTI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XBJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2CN8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH REMARK 900 DEBROMOHYMENIALDISINE REMARK 900 RELATED ID: 2W0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555 , A SPECIFIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2YCF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV1531 REMARK 900 RELATED ID: 2WTC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XM9 RELATED DB: PDB REMARK 900 STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF REMARK 900 CHK2 REMARK 900 RELATED ID: 2W7X RELATED DB: PDB REMARK 900 CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF REMARK 900 CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 REMARK 900 RELATED ID: 2YCQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV1115 REMARK 900 RELATED ID: 1GXC RELATED DB: PDB REMARK 900 FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC REMARK 900 PHOSPHOPEPTIDE REMARK 900 RELATED ID: 2CN5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP REMARK 900 RELATED ID: 2XM8 RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF A SMALL MOLECULE INHIBITOR BOUND TO THE REMARK 900 KINASE DOMAIN OF CHK2 REMARK 900 RELATED ID: 2WTD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2YCS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788 DBREF 2YCR A 210 531 UNP O96017 CHK2_HUMAN 210 531 SEQADV 2YCR MET A 209 UNP O96017 EXPRESSION TAG SEQADV 2YCR LYS A 508 UNP O96017 LEU 508 CONFLICT SEQRES 1 A 323 MET SER VAL TYR PRO LYS ALA LEU ARG ASP GLU TYR ILE SEQRES 2 A 323 MET SER LYS THR LEU GLY SER GLY ALA CYS GLY GLU VAL SEQRES 3 A 323 LYS LEU ALA PHE GLU ARG LYS THR CYS LYS LYS VAL ALA SEQRES 4 A 323 ILE LYS ILE ILE SER LYS ARG LYS PHE ALA ILE GLY SER SEQRES 5 A 323 ALA ARG GLU ALA ASP PRO ALA LEU ASN VAL GLU THR GLU SEQRES 6 A 323 ILE GLU ILE LEU LYS LYS LEU ASN HIS PRO CYS ILE ILE SEQRES 7 A 323 LYS ILE LYS ASN PHE PHE ASP ALA GLU ASP TYR TYR ILE SEQRES 8 A 323 VAL LEU GLU LEU MET GLU GLY GLY GLU LEU PHE ASP LYS SEQRES 9 A 323 VAL VAL GLY ASN LYS ARG LEU LYS GLU ALA THR CYS LYS SEQRES 10 A 323 LEU TYR PHE TYR GLN MET LEU LEU ALA VAL GLN TYR LEU SEQRES 11 A 323 HIS GLU ASN GLY ILE ILE HIS ARG ASP LEU LYS PRO GLU SEQRES 12 A 323 ASN VAL LEU LEU SER SER GLN GLU GLU ASP CYS LEU ILE SEQRES 13 A 323 LYS ILE THR ASP PHE GLY HIS SER LYS ILE LEU GLY GLU SEQRES 14 A 323 THR SER LEU MET ARG THR LEU CYS GLY THR PRO THR TYR SEQRES 15 A 323 LEU ALA PRO GLU VAL LEU VAL SER VAL GLY THR ALA GLY SEQRES 16 A 323 TYR ASN ARG ALA VAL ASP CYS TRP SER LEU GLY VAL ILE SEQRES 17 A 323 LEU PHE ILE CYS LEU SER GLY TYR PRO PRO PHE SER GLU SEQRES 18 A 323 HIS ARG THR GLN VAL SER LEU LYS ASP GLN ILE THR SER SEQRES 19 A 323 GLY LYS TYR ASN PHE ILE PRO GLU VAL TRP ALA GLU VAL SEQRES 20 A 323 SER GLU LYS ALA LEU ASP LEU VAL LYS LYS LEU LEU VAL SEQRES 21 A 323 VAL ASP PRO LYS ALA ARG PHE THR THR GLU GLU ALA LEU SEQRES 22 A 323 ARG HIS PRO TRP LEU GLN ASP GLU ASP MET LYS ARG LYS SEQRES 23 A 323 PHE GLN ASP LEU LEU SER GLU GLU ASN GLU SER THR ALA SEQRES 24 A 323 LYS PRO GLN VAL LEU ALA GLN PRO SER THR SER ARG LYS SEQRES 25 A 323 ARG PRO ARG GLU GLY GLU ALA GLU GLY ALA GLU HET HCW A 600 34 HET NO3 A 601 4 HETNAM HCW 1,3-BIS{4-[(1E)-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL) HETNAM 2 HCW ETHANEHYDRAZONOYL]PHENYL}UREA HETNAM NO3 NITRATE ION FORMUL 2 HCW C23 H28 N10 O FORMUL 3 NO3 N O3 1- FORMUL 4 HOH *145(H2 O) HELIX 1 1 PRO A 213 GLU A 219 1 7 HELIX 2 2 ASN A 269 LEU A 280 1 12 HELIX 3 3 LEU A 309 VAL A 314 1 6 HELIX 4 4 LYS A 320 ASN A 341 1 22 HELIX 5 5 LYS A 349 GLU A 351 5 3 HELIX 6 6 THR A 378 LEU A 384 1 7 HELIX 7 7 ALA A 392 SER A 398 1 7 HELIX 8 8 VAL A 399 THR A 401 5 3 HELIX 9 9 ARG A 406 GLY A 423 1 18 HELIX 10 10 SER A 435 GLY A 443 1 9 HELIX 11 11 ILE A 448 ALA A 453 1 6 HELIX 12 12 SER A 456 LEU A 467 1 12 HELIX 13 13 THR A 476 ARG A 482 1 7 HELIX 14 14 HIS A 483 GLN A 487 5 5 HELIX 15 15 ASP A 488 ASN A 503 1 16 SHEET 1 AA 5 TYR A 220 GLY A 227 0 SHEET 2 AA 5 GLU A 233 GLU A 239 -1 O VAL A 234 N LEU A 226 SHEET 3 AA 5 LYS A 244 ILE A 251 -1 O LYS A 244 N GLU A 239 SHEET 4 AA 5 TYR A 297 GLU A 302 -1 O TYR A 297 N ILE A 251 SHEET 5 AA 5 ILE A 288 ASP A 293 -1 N LYS A 289 O VAL A 300 SHEET 1 AB 3 GLY A 307 GLU A 308 0 SHEET 2 AB 3 VAL A 353 LEU A 355 -1 N LEU A 355 O GLY A 307 SHEET 3 AB 3 ILE A 364 ILE A 366 -1 O LYS A 365 N LEU A 354 SHEET 1 AC 2 ILE A 343 ILE A 344 0 SHEET 2 AC 2 LYS A 373 ILE A 374 -1 O LYS A 373 N ILE A 344 CISPEP 1 GLU A 504 SER A 505 0 -9.89 SITE 1 AC1 15 LYS A 224 LEU A 226 VAL A 234 LYS A 249 SITE 2 AC1 15 GLU A 273 LEU A 301 MET A 304 GLU A 305 SITE 3 AC1 15 GLY A 307 LEU A 354 THR A 367 ASP A 368 SITE 4 AC1 15 GLY A 370 HOH A2144 HOH A2145 SITE 1 AC2 5 LEU A 375 GLY A 403 TYR A 404 ASN A 405 SITE 2 AC2 5 ARG A 406 CRYST1 90.801 90.801 93.382 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011013 0.006358 0.000000 0.00000 SCALE2 0.000000 0.012717 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010709 0.00000